AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 148 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,542,663 | -61.3% | 4,160,292 | -32.8% | 0.00% | -75.0% |
| Q2 2023 | $68,642,586 | +2.2% | 6,189,593 | +41.4% | 0.00% | 0.0% |
| Q1 2023 | $67,187,871 | -57.6% | 4,377,060 | -38.7% | 0.00% | -20.0% |
| Q4 2022 | $158,442,236 | +451.2% | 7,140,254 | +305.6% | 0.01% | +150.0% |
| Q3 2022 | $28,746,000 | +7.7% | 1,760,331 | -4.2% | 0.00% | 0.0% |
| Q2 2022 | $26,701,000 | -12.0% | 1,837,675 | +11.9% | 0.00% | +100.0% |
| Q1 2022 | $30,325,000 | -8.7% | 1,641,867 | +17.5% | 0.00% | -50.0% |
| Q4 2021 | $33,216,000 | -5.6% | 1,397,403 | -2.2% | 0.00% | 0.0% |
| Q3 2021 | $35,196,000 | +6.1% | 1,429,004 | +6.4% | 0.00% | 0.0% |
| Q2 2021 | $33,188,000 | +12.8% | 1,343,118 | -0.4% | 0.00% | 0.0% |
| Q1 2021 | $29,415,000 | +69.3% | 1,348,673 | +98.0% | 0.00% | +100.0% |
| Q4 2020 | $17,379,000 | +152.6% | 680,994 | +178.6% | 0.00% | – |
| Q3 2020 | $6,881,000 | – | 244,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |